Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results.
Stephan BaldusNiklas SchoferJörg HausleiterKai FriedrichsP LurzPhilipp LuedikeChristian FrerkerG NickenigEdith LubosRoman PfisterM I KörberDaniel KalbacherMichael NäbauerC BeslerAmir Abbas MahabadiMarcel WeberM ZdanyteC B RenTobias GeislerPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
Experience with the PASCAL transcatheter valve repair system in a European post-market setting confirms favorable safety and effectiveness at 30 days. TR significantly reduced, and clinical, functional, and quality-of-life outcomes significantly improved. This study is ongoing. Clinical Trial Registration: The study is ongoing and registered on ClinicalTrials.gov as NCT04614402. The current analysis is an interim report.